VOGLIOS RP 0.3/1

VOGLIOS RP 0.3/1 is a combination anti-diabetic medication containing Voglibose 0.3 mg and Repaglinide 1 mg, formulated to help manage Type 2 Diabetes Mellitus. This dual-mechanism therapy supports better control of post-prandial (after-meal) blood glucose levels and improves overall glycemic management.

 

Key Benefits 

•  Helps control post-meal blood sugar spikes
•  Improves overall glycemic control
•  Rapid action for better glucose management
•  Supports long-term diabetes management
•  Suitable for combination therapy in Type 2 diabetes